Scrip 100

The latest Scrip 100 data set is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2023).


View Ranking

The Scrip 100: Changes At The Top Of The Leaderboard

 
• By Jessica Merrill

Pfizer continued its reign as the Scrip 100 leader for a third year, while Lilly and Novo climbed higher.

Scrip 100: By The Numbers

 
• By Edwin Elmhirst and Kosh Naran

Despite experiencing significant drops in pharmaceutical revenues in 2023, Pfizer and AbbVie maintained their top positions, ranking first and second respectively, in the latest Scrip 100.